347782
Early diagnosis of disease can be done by the technique
1 ELISA
2 PCR
3 Recombinant DNA technology
4 All the above
Explanation:
ELISA, PCR and Recombinant DNA Technology are the techniques used for early diagnosis of diseases.
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347700
The first clinical gene therapy was done for the treatment of:
1 AIDS
2 Cancer
3 Cystic fibrosis
4 SCID (Severe Combined Immuno Deficiency resulting from deficiency of ADA)
Explanation:
The first clinical gene therapy was given in 1990 to a 4-year old girl with adenosine deaminase (ADA) deficiency.
NCERTExemplar
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347699
The site of production of ADA in the body is
1 Blood plasma
2 Osteocytes
3 Lymphocytes
4 Erythrocytes
Explanation:
\(\mathrm{ADA}\) is an enzyme present in lymphocytes and is very important to the immune system to function.
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347697
Assertion : Due to excessive synthesis of gene for adenosine deaminase ADA deficiency disorder is caused. Reason : It affects the human digestive system.
1 Both Assertion and Reason are correct and Reason is the correct explanation of the Assertion.
2 Both Assertion and Reason are correct but Reason is not the correct explanation of the Assertion.
3 Assertion is correct but Reason is incorrect.
4 Both Assertion and Reason are incorrect.
Explanation:
ADA disorder is caused because of lack of gene for adenosine deaminase. It affects the human immune system.
347782
Early diagnosis of disease can be done by the technique
1 ELISA
2 PCR
3 Recombinant DNA technology
4 All the above
Explanation:
ELISA, PCR and Recombinant DNA Technology are the techniques used for early diagnosis of diseases.
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347700
The first clinical gene therapy was done for the treatment of:
1 AIDS
2 Cancer
3 Cystic fibrosis
4 SCID (Severe Combined Immuno Deficiency resulting from deficiency of ADA)
Explanation:
The first clinical gene therapy was given in 1990 to a 4-year old girl with adenosine deaminase (ADA) deficiency.
NCERTExemplar
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347699
The site of production of ADA in the body is
1 Blood plasma
2 Osteocytes
3 Lymphocytes
4 Erythrocytes
Explanation:
\(\mathrm{ADA}\) is an enzyme present in lymphocytes and is very important to the immune system to function.
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347697
Assertion : Due to excessive synthesis of gene for adenosine deaminase ADA deficiency disorder is caused. Reason : It affects the human digestive system.
1 Both Assertion and Reason are correct and Reason is the correct explanation of the Assertion.
2 Both Assertion and Reason are correct but Reason is not the correct explanation of the Assertion.
3 Assertion is correct but Reason is incorrect.
4 Both Assertion and Reason are incorrect.
Explanation:
ADA disorder is caused because of lack of gene for adenosine deaminase. It affects the human immune system.
347782
Early diagnosis of disease can be done by the technique
1 ELISA
2 PCR
3 Recombinant DNA technology
4 All the above
Explanation:
ELISA, PCR and Recombinant DNA Technology are the techniques used for early diagnosis of diseases.
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347700
The first clinical gene therapy was done for the treatment of:
1 AIDS
2 Cancer
3 Cystic fibrosis
4 SCID (Severe Combined Immuno Deficiency resulting from deficiency of ADA)
Explanation:
The first clinical gene therapy was given in 1990 to a 4-year old girl with adenosine deaminase (ADA) deficiency.
NCERTExemplar
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347699
The site of production of ADA in the body is
1 Blood plasma
2 Osteocytes
3 Lymphocytes
4 Erythrocytes
Explanation:
\(\mathrm{ADA}\) is an enzyme present in lymphocytes and is very important to the immune system to function.
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347697
Assertion : Due to excessive synthesis of gene for adenosine deaminase ADA deficiency disorder is caused. Reason : It affects the human digestive system.
1 Both Assertion and Reason are correct and Reason is the correct explanation of the Assertion.
2 Both Assertion and Reason are correct but Reason is not the correct explanation of the Assertion.
3 Assertion is correct but Reason is incorrect.
4 Both Assertion and Reason are incorrect.
Explanation:
ADA disorder is caused because of lack of gene for adenosine deaminase. It affects the human immune system.
347782
Early diagnosis of disease can be done by the technique
1 ELISA
2 PCR
3 Recombinant DNA technology
4 All the above
Explanation:
ELISA, PCR and Recombinant DNA Technology are the techniques used for early diagnosis of diseases.
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347700
The first clinical gene therapy was done for the treatment of:
1 AIDS
2 Cancer
3 Cystic fibrosis
4 SCID (Severe Combined Immuno Deficiency resulting from deficiency of ADA)
Explanation:
The first clinical gene therapy was given in 1990 to a 4-year old girl with adenosine deaminase (ADA) deficiency.
NCERTExemplar
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347699
The site of production of ADA in the body is
1 Blood plasma
2 Osteocytes
3 Lymphocytes
4 Erythrocytes
Explanation:
\(\mathrm{ADA}\) is an enzyme present in lymphocytes and is very important to the immune system to function.
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347697
Assertion : Due to excessive synthesis of gene for adenosine deaminase ADA deficiency disorder is caused. Reason : It affects the human digestive system.
1 Both Assertion and Reason are correct and Reason is the correct explanation of the Assertion.
2 Both Assertion and Reason are correct but Reason is not the correct explanation of the Assertion.
3 Assertion is correct but Reason is incorrect.
4 Both Assertion and Reason are incorrect.
Explanation:
ADA disorder is caused because of lack of gene for adenosine deaminase. It affects the human immune system.
347782
Early diagnosis of disease can be done by the technique
1 ELISA
2 PCR
3 Recombinant DNA technology
4 All the above
Explanation:
ELISA, PCR and Recombinant DNA Technology are the techniques used for early diagnosis of diseases.
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347700
The first clinical gene therapy was done for the treatment of:
1 AIDS
2 Cancer
3 Cystic fibrosis
4 SCID (Severe Combined Immuno Deficiency resulting from deficiency of ADA)
Explanation:
The first clinical gene therapy was given in 1990 to a 4-year old girl with adenosine deaminase (ADA) deficiency.
NCERTExemplar
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347699
The site of production of ADA in the body is
1 Blood plasma
2 Osteocytes
3 Lymphocytes
4 Erythrocytes
Explanation:
\(\mathrm{ADA}\) is an enzyme present in lymphocytes and is very important to the immune system to function.
BIOXII12: BIOTECHNOLOGY AND ITS APPLICATIONS
347697
Assertion : Due to excessive synthesis of gene for adenosine deaminase ADA deficiency disorder is caused. Reason : It affects the human digestive system.
1 Both Assertion and Reason are correct and Reason is the correct explanation of the Assertion.
2 Both Assertion and Reason are correct but Reason is not the correct explanation of the Assertion.
3 Assertion is correct but Reason is incorrect.
4 Both Assertion and Reason are incorrect.
Explanation:
ADA disorder is caused because of lack of gene for adenosine deaminase. It affects the human immune system.